Compositions comprosing memantine and polyanionic polymers for administration to the eye

Details for Australian Patent Application No. 2005204365 (hide)

Owner Allergan, Inc.

Inventors Hughes, Patrick M.; Schiffman, Rhett; Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-A-2005204365

PCT Pub. Number WO2005/067891

Priority 10/752,125 05.01.04 US; 10/941,272 14.09.04 US

Filing date 4 January 2005

Wipo publication date 28 July 2005

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/067891 Priority application(s): WO2005/067891

17 August 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Compositions comprising memantine and polyanionic polymers for administration to the eye

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204368-Ormosil aerogels containing silicon bonded linear polymers

2005204364-Separable portion containers